Download PDF
Semin Reprod Med 2004; 22(3): 219-225
DOI: 10.1055/s-2004-831897
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Inhibins as Biomarkers for Reproductive Cancers

David M. Robertson1 , Jane McNeilage1
  • 1Prince Henry's Institute of Medical Research and Department of Obstetrics and Gynecology, Monash University, Clayton, Victoria, Australia
Further Information

Publication History

Publication Date:
20 August 2004 (online)

    Permissions and Reprints

Inhibin is a dimeric (α and either βA or βB subunit) protein involved in the regulation of fertility. Inhibin A and B or its free α subunit monomer are elevated in various gonadal and prostate cancers and thus serve as useful diagnostic tools for certain ovarian tumors either as a serum marker or as an immunocytochemical marker for tissue sections. Serum inhibin levels are of value in the initial diagnosis and subsequent follow-up of sex cord stromal tumors, in particular granulosa cell tumors, and mucinous epithelial adenocarcinomas primarily after menopause. Immunocytochemistry using inhibin α subunit antisera can aid in the classification of sex cord stromal tumors and their differentiation from other cancers. Although serum inhibins are elevated in prostatic and testicular cancers, this is of little diagnostic value at the present time.

KEYWORDS

Ovarian cancer - granulosa cell tumors - mucinous carcinomas - inhibin α subunit - prostate cancer

REFERENCES

  • 1 de Kretser D M, Hedger M P, Loveland K L, Phillips D J. Inhibins, activins and follistatin in reproduction.  Hum Reprod Update. 2002;  8 529-541
    CrossrefPubMedGoogle Scholar
  • 2 Knight P G, Glister C. Local role of TGF-beta superfamily members in the control of ovarian follicle development.  Anim Reprod Sci. 2003;  78 165-183
    PubMedGoogle Scholar
  • 3 Lappohn R E, Burger H G, Bouma J, Bangah M, Krans M, de Bruijn H WA. Inhibin as a marker for granulosa cell tumours.  N Engl J Med. 1989;  321 790-793
    PubMedGoogle Scholar
  • 4 Matzuk M M, Finegold M J, Su J G, Hseuh A J, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice.  Nature. 1992;  360 313-319
    CrossrefPubMedGoogle Scholar
  • 5 Robertson D, Cahir N, Findlay J K, Burger H G, Groome N. The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma.  J Clin Endocrinol Metab. 1997;  82 889-896
    CrossrefPubMedGoogle Scholar
  • 6 Lambert-Messerlian G M, Steinhoff M, Zheng W et al.. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.  Gynecol Oncol. 1997;  65 512-516
    CrossrefPubMedGoogle Scholar
  • 7 Petraglia F, Luisi S, Pautier P et al.. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumours.  J Clin Endocrinol Metab. 1998;  83 1029-1032
    CrossrefPubMedGoogle Scholar
  • 8 Robertson D M, Stephenson T, Pruysers E et al.. Characterisation of inhibin forms and their measurement by an inhibin α subunit ELISA in serum from postmenopausal women with ovarian cancer.  J Clin Endocrinol Metab. 2002;  87 816-824
    CrossrefPubMedGoogle Scholar
  • 9 Robertson D M, Cahir N, Burger H G, Mamers P, Groome N. Inhibin forms in serum from postmenopausal women with ovarian cancers.  Clin Endocrinol (Oxf). 1999;  50 381-386
    CrossrefPubMedGoogle Scholar
  • 10 Boggess J F, Soules M R, Goff B A, Greer B E, Cain J M, Tamimi H K. Serum inhibin and disease status in women with ovarian granulosa cell tumors.  Gynecol Oncol. 1997;  64 64-69
    CrossrefPubMedGoogle Scholar
  • 11 Schumer S T, Cannistra S A. Granulosa cell tumor of the ovary.  J Clin Oncol. 2003;  21 1180-1189
    CrossrefPubMedGoogle Scholar
  • 12 Sluijmer A V, Heineman M J, Evers J LH, de Jong F H. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumour.  Acta Endocrinol (Copenh). 1993;  129 311-314
    PubMedGoogle Scholar
  • 13 Jobling T, Mamers P, MacLachlan V et al.. A prospective study of inhibin in granulosa cell tumours of the ovary.  Gynecol Oncol. 1994;  55 285-289
    CrossrefPubMedGoogle Scholar
  • 14 Cooke I, O'Brien M, Charnock F M, Groome N, Ganesan T S. Inhibin as a marker for ovarian cancer.  Br J Cancer. 1995;  71 1046-1050
    PubMedGoogle Scholar
  • 15 McCluggage W G. Recent advances in immunochemistry in gynaecological pathology.  Histopathology. 2002;  40 309-326
    CrossrefPubMedGoogle Scholar
  • 16 Zheng W, Senturk B Z, Parkash V. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnosis of ovarian sex cord-stromal tumors.  Adv Anat Pathol. 2003;  10 27-38
    PubMedGoogle Scholar
  • 17 Risbridger G P, Schmitt J F, Robertson D M. Activin and inhibin in endocrine and other cancers.  Endocr Rev. 2001;  22 836-858
    CrossrefPubMedGoogle Scholar
  • 18 Ala-Fossi S L, Aine R, Punnonen R, Maenpaa J. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumours?.  Eur J Gynaecol Oncol. 2000;  21 187-189
    PubMedGoogle Scholar
  • 19 Gebhart J B, Roche P C, Keney G L, Lesnick T G, Podratz K C. Assessment of inhibin and p53 in granulosa cell tumors of the ovary.  Gynecol Oncol. 2000;  77 232-236
    CrossrefPubMedGoogle Scholar
  • 20 Healy D L, Burger H G, Mamers P et al.. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours.  N Engl J Med. 1993;  329 1539-1542
    CrossrefPubMedGoogle Scholar
  • 21 Burger H G, Fuller P J, Chu S et al.. The inhibins and ovarian cancer.  Mol Cell Endocrinol. 2001;  180 145-148
    CrossrefPubMedGoogle Scholar
  • 22 Fuller P J, Chu S, Jobling T, Mamers P, Healy D L, Burger H G. Inhibin subunit gene expression in ovarian cancer.  Gynecol Oncol. 1999;  73 273-279
    CrossrefPubMedGoogle Scholar
  • 23 Cobellis L, Cataldi P, Reis F M et al.. Gonadal malignant germ cell tumours express immunoreactive inhibin/activin subunits.  Eur J Endocrinol. 2001;  145 779-784
    CrossrefPubMedGoogle Scholar
  • 24 Zheng W, Lu J J, Luo F et al.. Tumour stroma as the main source of inhibin production in ovarian epithelial tumours.  Am J Reprod Immunol. 2000;  44 104-113
    CrossrefPubMedGoogle Scholar
  • 25 Robertson D M, Stephenson T, Cahir N et al.. Development of an inhibin α subunit ELISA with broad specificity.  Mol Cell Endocrinol. 2001;  180 79-86
    CrossrefPubMedGoogle Scholar
  • 26 Robertson D M, Pruysers E, Burger H G, Jobling T, McNeilage J, Healy D. Inhibins and ovarian cancer.  Mol Cell Endocrinol. , in press
    PubMedGoogle Scholar
  • 27 Skates S J, Menon U, MacDonald N et al.. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.  J Clin Oncol. 2003;  21 206-210
    CrossrefPubMedGoogle Scholar
  • 28 Lambert-Messerlian G M, DePasquale S E, Maybruck W M, Steinhoff M, Gajewski W H. Secretion of activin A in recurrent epithelial ovarian carcinoma.  Gynecol Oncol. 1999;  74 93-97
    CrossrefPubMedGoogle Scholar
  • 29 Risbridger G P, Mellor S L, McPherson S J, Schmitt J F. The contribution of inhibin and activins to malignant prostate disease.  Mol Cell Endocrinol. 2001;  180 149-153
    CrossrefPubMedGoogle Scholar
  • 30 Risbridger G P, Ball E M, Wang H, Mellor S, Peehl D M. Evaluation of inhibin α subunit as a tumour suppressor in prostate cancer.  Mol Cell Endocrinol. , in press
    PubMedGoogle Scholar
  • 31 McCluggage W G, Shanks J H, Whiteside C, Maxwell P, Banerjee S S, Biggart J D. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody.  Am J Surg Pathol. 1998;  22 615-619
    CrossrefPubMedGoogle Scholar
  • 32 Iczkowski K A, Bostwick D G, Roche P C, Cheville J C. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.  Mod Pathol. 1998;  11 774-779
    PubMedGoogle Scholar
  • 33 Toppari J, Kaipia A, Kaleva M et al.. Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels.  APMIS. 1998;  106 101-112
    PubMedGoogle Scholar
  • 34 Jones R L, Salamonsen L A, Critchley H OD, Rogers P AW, Affandi B, Findlay J K. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception.  Mol Hum Reprod. 2000;  6 1107-1117
    CrossrefPubMedGoogle Scholar
  • 35 Fuller P J, Zumpe E T, Chu S, Mamers P, Burger H G. Inhibin-activin receptor subunit gene expression in ovarian tumours.  J Clin Endocrinol Metab. 2002;  87 1395-1401
    CrossrefPubMedGoogle Scholar
  • 36 Robertson D M, Stephenson T, Pruysers E et al.. Inhibins/activins as diagnostic markers for ovarian cancer.  Mol Cell Endocrinol. 2002;  191 97-163
    CrossrefPubMedGoogle Scholar

David M RobertsonPh.D. 

Prince Henry's Institute of Medical Research

P.O. Box 5152, Clayton

Victoria 3168, Australia

      >